Community-reported Bevacizumab side effects:
facial palsy 2008-10-14 20:47:00
Add Your Side Effect to the Community Database
Help Community - Describe Your Bevacizumab Side Effect
Have You dealt with a Bevacizumab side effect? Share your experience
Review Bevacizumab Safety Reports submitted to FDA
Total Bevacizumab reports: 2166.Bevacizumab FDA safety alerts: 2004 2005 2006 2007 .
Reported deaths: 488 Reported hospitalizations: 1628.
Take Bevacizumab Side Effects Survey, Discuss Bevacizumab with others
FDA Reported Bevacizumab Side Effects: pyrexia, dehydration, diarrhoea, nausea, vomiting, asthenia, disease progression, pulmonary embolism, death, renal failure acute, anaemia haemolytic autoimmune.
More About Bevacizumab.
If you have questions about Bevacizumab, you can ask a Health Expert or Ask Patient Community about Bevacizumab.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
< Previous Showing 301-400 of 2166 Next >
Bevacizumab Side Effects Report #5585417-4Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 27, 2007. Male patient, weighting 125.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: respiratory failure. BEVACIZUMAB dosage: 855 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ERLOTINIB, FRAXIPARINE. Patient recovered.
Bevacizumab Side Effects Report #5585675-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 07, 2008. Female patient, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: leukoencephalopathy. BEVACIZUMAB dosage: 536 MG, Q2W. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 10/21/2007.
Bevacizumab Side Effects Report #5585789-0
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 26, 2007. Female patient, 73 years of age, weighting 127.9 lb, was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, renal failure acute. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.
Bevacizumab Side Effects Report #5585831-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 26, 2007. Male patient was diagnosed with rectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, hypertension. BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5585847-0
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 27, 2007. Female patient was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, interstitial lung disease. BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586042-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 03, 2008. Female patient, 48 years of age, weighting 118.2 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, deep vein thrombosis. BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, PROCHLORPERAZINE, PREDNISONE, DIOVAN, HYDROMORPHONE, INSULIN GLARGINE, INSULIN LISPRO, CHLORTHIAZIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586354-1
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 07, 2008. Male patient, weighting 184.3 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: colonic stenosis. BEVACIZUMAB dosage: 1200 MG. During the same period patient was treated with ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586779-4
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 28, 2007. Male patient, 74 years of age, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, ISOVORIN, WARFARIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586782-4
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 27, 2007. Male patient was diagnosed with colorectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, pain, pyrexia. BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, COZAAR, METFORMIN, ATENOLOL, CIPRO, LOVASTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586895-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 10, 2008. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. BEVACIZUMAB dosage: 335 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5586945-8
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 27, 2007. Male patient was diagnosed with rectal cancer recurrent, cancer pain and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: aortic dissection, hypertension. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL, TEGRETOL, ETODOLAC, FENTANYL, PRIMPERAN. Patient recovered.
Bevacizumab Side Effects Report #5586978-1
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
Bevacizumab Side Effects Report #5587232-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 04, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.
Bevacizumab Side Effects Report #5587284-1
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Dec 26, 2007. Male patient was diagnosed with colorectal cancer metastatic, proctalgia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal haemorrhage. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with LOXONIN, OXALIPLATIN, FLUOROURACIL, ISOVORIN, NORVASC, ADALAT, BASEN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5587559-6
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 02, 2008. Male patient, weighting 205.0 lb, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. BEVACIZUMAB dosage: 473 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, LEUCOVORIN, FLUOROURACIL, DECADRON, PROCHLORPERAZINE, METFORMIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5587568-7
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 03, 2008. Female patient, 54 years of age, weighting 170.2 lb, was diagnosed with breast cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation. BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, VERAPAMIL, GLUCOPHAGE, XANAX, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5588243-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.
Bevacizumab Side Effects Report #5588639-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 07, 2008. Male patient, weighting 130.0 lb, was diagnosed with neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchitis. BEVACIZUMAB dosage: 15 MG/KG, WKS 1 + 4. During the same period patient was treated with ERLOTINIB, PACLITAXEL, HALDOL, FLUCONAZOLE, LYRICA, ALPRAZOLAM, CITALOPRAM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5588813-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 02, 2008. Male patient, weighting 174.2 lb, was diagnosed with metastatic gastric cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: ileus, neutropenia, pyrexia. BEVACIZUMAB dosage: 10 MG/M2, Q3W. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5588851-1
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Male patient, 63 years of age, weighting 187.6 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with IRINOTECAN. Patient died on 12/26/2007.
Bevacizumab Side Effects Report #5588898-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 04, 2008. Female patient was diagnosed with neuroblastoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. BEVACIZUMAB dosage: unknown. During the same period patient was treated with LIOTHYRONINE, POTASSIUM IODIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5588941-3
BEVACIZUMAB problem was reported by a Physician from SPAIN on Dec 28, 2007. Male patient, weighting 112.4 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. BEVACIZUMAB dosage: 390 MG, Q3W. During the same period patient was treated with CAPECITABINE, LOPERAMIDE, GLUTAMINE, METOCLOPRAMIDA, PANTOPRAZOLE, RANIDINE, METAMIZOL. Patient died on 12/23/2007.
Bevacizumab Side Effects Report #5590300-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 10, 2008. Female patient, weighting 121.3 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, failure to thrive. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, MORPHINE. Patient died on 01/21/2007.
Bevacizumab Side Effects Report #5591454-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient, 85 years of age, was diagnosed with renal cell carcinoma, insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5591654-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 07, 2008. Male patient, weighting 185.0 lb, was diagnosed with non-small cell lung cancer, prophylaxis, gastrooesophageal reflux disease, hypercholesterolaemia, hypertension, bone pain and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia. BEVACIZUMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL, PLAVIX, NEXIUM, CRESTOR, RANEXA, NORVASC, OXYCODONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5591978-1
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 10, 2008. Female patient, weighting 149.5 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hepatic failure. BEVACIZUMAB dosage: 1101 MG, Q3W. During the same period patient was treated with DOCETAXEL, METADON, OMEPRAZOLE, BROMOPRIDE, DOXORUBICIN, PACLITAXEL, TAMOXIFEN, ANASTROZOLE. Patient recovered.
Bevacizumab Side Effects Report #5592279-8
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Female patient was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: microangiopathic haemolytic anaemia, thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.
Bevacizumab Side Effects Report #5592292-0
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 07, 2008. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, septic shock. BEVACIZUMAB dosage: unknown. During the same period patient was treated with CISPLATIN, GLYBURIDE, GUAIFENESIN, LISINOPRIL, ONDANSETRON, PIOGLITAZONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5592311-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 10, 2008. Female patient, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression. BEVACIZUMAB dosage: 536 MG, Q2W. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient died on 10/21/2007.
Bevacizumab Side Effects Report #5592343-3
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Male patient, weighting 214.0 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal necrosis, leukocytosis. BEVACIZUMAB dosage: 10 MG/KG, DAYS 2+16. During the same period patient was treated with PACLITAXEL, CISPLATIN, FLUOROURACIL, AMIODARONE, ATORVASTATIN, INULIN, LOPRESSOR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593106-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Jan 14, 2008. Male patient, weighting 176.4 lb, was diagnosed with metastatic gastric cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal distension, anaemia, gastrointestinal haemorrhage, vomiting. BEVACIZUMAB dosage: 10MG/M2 IV BOLUS. During the same period patient was treated with DOCETAXEL, CISPLATIN, IRINOTECAN D. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593172-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 02, 2008. Male patient, weighting 183.0 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: atrial flutter. BEVACIZUMAB dosage: 622 MG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, MOVALIS, ADOLONTA, DAONIL, SPIRIVA, FLUTICASONE PROPIONATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593700-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 10, 2008. Female patient, weighting 125.0 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: intestinal perforation. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, MOTRIN, DARVOCET, VYTORIN, XANAX. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593707-4
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Jan 08, 2008. Female patient, weighting 99.98 lb, was diagnosed with breast cancer, hypertension, hypercholesterolaemia, prophylaxis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, renal failure. BEVACIZUMAB dosage: 509 MG, Q4W. During the same period patient was treated with PACLITAXEL, FOLIC ACID, TOPROL, PLAVIX, IMDUR, CIMETIDINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593773-6
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Male patient, 44 years of age, weighting 172.2 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: brain oedema, confusional state, nuclear magnetic resonance imaging brain abnormal, somnolence. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with KEPPRA, TEMOZOLOMIDE, STEROIDS, PAXIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5593879-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.
Bevacizumab Side Effects Report #5593929-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy. BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
Bevacizumab Side Effects Report #5594005-5
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 16, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, LOXONIN. Patient recovered.
Bevacizumab Side Effects Report #5594014-6
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 16, 2008. Female patient, weighting 141.1 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hepatic failure. BEVACIZUMAB dosage: 1006 MG, Q3W. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient died on 09/13/2007.
Bevacizumab Side Effects Report #5594024-9
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Jan 16, 2008. Female patient, weighting 211.6 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: haemorrhoids. BEVACIZUMAB dosage: 958 MG, Q2W. During the same period patient was treated with TEMOZOLOMIDE, DECADRON, DOXYCYCLINE, HYOSCYAMINE, KEPPRA, NEXIUM, ZOFRAN, ZOLOFT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5594060-2
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 02, 2008. Female patient was diagnosed with gastrointestinal carcinoma, dyspepsia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, gastrointestinal haemorrhage, haemoglobin decreased, hyperglycaemia. BEVACIZUMAB dosage: 450 MG, Q2W. During the same period patient was treated with ERLOTINIB, MORPHINE, MEGACE, PANTOLOC, IMODIUM, BRUFEN, MYCOSTATIN, IMOZOP. Patient was hospitalized. Patient died on 11/21/2007.
Bevacizumab Side Effects Report #5594078-X
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Jan 08, 2008. Female patient, weighting 169.8 lb, was diagnosed with colon cancer, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: flushing. BEVACIZUMAB dosage: 5 MG/KG, Q14D. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN, FLUOROURACIL, LISINOPRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5594084-5
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 02, 2008. Male patient, weighting 153.9 lb, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. BEVACIZUMAB dosage: 524 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient recovered.
Bevacizumab Side Effects Report #5594690-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. BEVACIZUMAB dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, VALIUM, PROTONIX. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5594697-0
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 03, 2008. Female patient, weighting 108.2 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysarthria, dysphasia. BEVACIZUMAB dosage: 855 MG, UNK. During the same period patient was treated with ASPIRIN, MONOPLUS, CLODRONATE, AMOXICILLIN, BUSCOPAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5594849-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2008. Male patient, 63 years of age, weighting 187.6 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with IRINOTECAN. Patient died on 12/26/2007.
Bevacizumab Side Effects Report #5595193-7
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 10, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, atrial fibrillation, dehydration, sepsis. BEVACIZUMAB dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, VALIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595315-8
BEVACIZUMAB problem was reported by a Consumer or non-health professional from CANADA on Jan 14, 2008. Male patient was diagnosed with prophylaxis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: iridocyclitis. BEVACIZUMAB dosage: 1.25 MG, UNK. During the same period patient was treated with VISUDYNE, DEXAMETHASONE, LIDOCAINE, PROVIODINE, VIGAMOX. Patient recovered.
Bevacizumab Side Effects Report #5595324-9
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 03, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, c-reactive protein increased, pyrexia, vomiting. BEVACIZUMAB dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595327-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 11, 2008. Female patient, weighting 135.1 lb, was diagnosed with breast cancer metastatic, oedema peripheral, prophylaxis, osteoporosis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: diverticulitis. BEVACIZUMAB dosage: 630 MG, UNK. During the same period patient was treated with ABRAXANE, PREDNISONE, ZOFRAN, DECADRON, BONIVA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595622-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 16, 2008. Male patient, 73 years of age, weighting 205.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, sepsis. BEVACIZUMAB dosage: 930MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5595700-4
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 04, 2008. Male patient was diagnosed with colon cancer metastatic, colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, partial seizures. BEVACIZUMAB dosage: 975 MG, Q3W. During the same period patient was treated with XELODA, MITOMYCIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595715-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 11, 2008. Female patient, 60 years of age, weighting 180.1 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: mental status changes. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595942-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 14, 2008. Female patient, weighting 155.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, impaired healing, wound evisceration. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5596039-3
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 08, 2008. Male patient, weighting 112.4 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression. BEVACIZUMAB dosage: 390 MG, Q3W. During the same period patient was treated with CAPECITABINE, LOPERAMIDE, GLUTAMINE, METOCLOPRAMIDA, PANTOPRAZOLE, RANIDINE, METAMIZOL. Patient died on 12/23/2007.
Bevacizumab Side Effects Report #5596057-5
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 07, 2008. Female patient was diagnosed with gastrointestinal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, deep vein thrombosis, pyrexia. BEVACIZUMAB dosage: 560 MG, Q2W. During the same period patient was treated with ERLOTINIB, BUPRENORPHINE HYDROCHLORIDE, PREDNISOLONE, LACTULOSE, NEXIUM, LAXOBERAL. Patient was hospitalized. Patient died on 02/25/2007.
Bevacizumab Side Effects Report #5596166-0
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 07, 2008. Female patient, weighting 100.1 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastroenteritis. BEVACIZUMAB dosage: 489 MG, Q2W. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5596196-9
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 15, 2008. Female patient, weighting 130.0 lb, was diagnosed with non-small cell lung cancer, pain and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypotension, pain in extremity. BEVACIZUMAB dosage: 690 MG, Q3W. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ALBUTEROL, HYDROCODONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5596405-6
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 07, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: pyrexia, respiratory failure. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, ADALAT, ENALAPRIL MALEATE, AMARYL, URINORM, LIPITOR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5598429-1
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 17, 2008. Female patient was diagnosed with breast cancer metastatic, gastrooesophageal reflux disease, fluid retention, asthma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: lethargy. BEVACIZUMAB dosage: 895.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, LANSOPRAZOLE, FUROSEMIDE, BECOTIDE, TERBUTALINE SULPHATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5598520-X
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 07, 2008. Male patient, weighting 175.0 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. BEVACIZUMAB dosage: 630 MG, Q3W. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, METFORMIN, ACTOS, LIPITOR, LISINOPRIL, COMPAZINE, LOMOTIL. Patient died on 01/06/2008.
Bevacizumab Side Effects Report #5598692-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Male patient, 66 years of age, was diagnosed with squamous cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, septic shock. BEVACIZUMAB dosage: unknown. During the same period patient was treated with CISPLATIN, GLYBURIDE, GUAIFENESIN, LISINOPRIL, ONDANSETRON, PIOGLITAZONE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5598697-6
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 07, 2008. Female patient, weighting 156.1 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: pleural effusion. BEVACIZUMAB dosage: 1113 MG, Q3W. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5598700-3
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Female patient, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia. BEVACIZUMAB dosage: 750 MG, Q3W. During the same period patient was treated with CARBOPLATIN, NAVELBINE, DOCETAXEL, VOLTAREN, PANTOZOL, AMITRIPTYLINE, PALLADONE, MORPHINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5598706-4
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 08, 2008. Male patient was diagnosed with colon cancer recurrent and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient died.
Bevacizumab Side Effects Report #5598955-5
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Male patient, 60 years of age, was diagnosed with colon cancer, colon cancer recurrent, prophylaxis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, IRINOTECAN, DECADRON, KYTRIL, MAGNESIUM OXIDE, STROCAIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5599719-9
Pharmacist from UNITED STATES reported BEVACIZUMAB problem on Jan 18, 2008. Female patient, 29 years of age, weighting 140.2 lb, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pharyngolaryngeal discomfort, urticaria. BEVACIZUMAB dosage: 314 MG (1ST DOSE IV). During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM, ZOFRAN, CIMETIDINE, DIPHENHYDRAMINE, DEXAMETHASONE, OXALIPLATIN. Patient recovered.
Bevacizumab Side Effects Report #5599815-6
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, convulsion, hydronephrosis, inadequate analgesia, malignant neoplasm progression, sepsis. BEVACIZUMAB dosage: 10 MG/KG INTRAVENOUS DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, EPIDURAL, DIPHENHYDRAMINE, ERTAPENEM. Patient died on 01/09/2008.
Bevacizumab Side Effects Report #5600213-7
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 18, 2008. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic, non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, hypoxia, mental status changes, oesophageal ulcer, oesophagitis, oxygen saturation decreased, pneumonia, radiation injury. BEVACIZUMAB dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5600618-4
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 08, 2008. Female patient, 40 years of age, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, intestinal obstruction. BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IRINOTECAN, KYTRIL, DECADRON, MAGNESIUM OXIDE, LOXOPROFEN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5600649-4
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Dec 19, 2007. Male patient, 52 years of age, was diagnosed with bile duct cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, hyperbilirubinaemia. BEVACIZUMAB dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5601543-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, atrial fibrillation, dehydration, sepsis. BEVACIZUMAB dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, PROTONIX, LORTAB, OXYCODONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5601698-2
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 10, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypertension, interstitial lung disease. BEVACIZUMAB dosage: 5 MG/KG, UNK. During the same period patient was treated with ISOVORIN, FLUOROURACIL, OXALIPLATIN, MIYA BM, NORVASC, URSO, TATHION, MAGNESIUM OXIDE. Patient died on 10/28/2007.
Bevacizumab Side Effects Report #5601703-3
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 09, 2008. Male patient, weighting 178.6 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, proteinuria. BEVACIZUMAB dosage: 610 MG, Q2W. During the same period patient was treated with CAPECITABINE, CAMPTO, TRIFLUCAN, ZOMETA, ALLOPURINOL, AMLOR, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5601708-2
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 09, 2008. Female patient, weighting 218.3 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: pyrexia. BEVACIZUMAB dosage: 1485 MG, Q3W. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5601760-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 16, 2008. Male patient, weighting 160.9 lb, was diagnosed with metastatic gastric cancer, hypotension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis. BEVACIZUMAB dosage: 10 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, IRINOTECAN, DOCETAXEL, DIGOXIN, ESMOLOL, LOPRESSOR, CALCIUM CARBONATE, DOCUSATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5602033-6
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 22, 2008. Male patient, 51 years of age, weighting 180.8 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cholangitis, stent occlusion. BEVACIZUMAB dosage: 830MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5602718-1
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 11, 2008. Female patient, weighting 108.2 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dysarthria, dysphasia. BEVACIZUMAB dosage: 855 MG, UNK. During the same period patient was treated with ASPIRIN, MONOPLUS, CLODRONATE, AMOXICILLIN, BUSCOPAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5602838-1
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 14, 2008. Male patient, weighting 191.8 lb, was diagnosed with acute myeloid leukaemia and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, aspergillosis, diarrhoea, enteritis, injury, nausea. BEVACIZUMAB dosage: 450 MG, UNK. During the same period patient was treated with DAUNOMYCIN, CYTARABINE, METOPROLOL TARTRATE, NEXIUM, CEFTAZIDIME, FLAGYL, MORPHINE, PREDNISOLONE. Patient died on 01/16/2008.
Bevacizumab Side Effects Report #5602994-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 17, 2008. Female patient was diagnosed with breast cancer metastatic, colon cancer metastatic, antifungal prophylaxis, gastrooesophageal reflux disease, asthma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, mucosal inflammation. BEVACIZUMAB dosage: 904 MG, UNK. During the same period patient was treated with ABRAXANE, NEUPOGEN, NYSTATIN, FAMOTIDINE, DEPAKOTE, LOVENOX, MONTELUKAST, ALBUTEROL SULPHATE. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5603008-3
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 11, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN. Patient recovered.
Bevacizumab Side Effects Report #5603045-9
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: peripheral sensory neuropathy. BEVACIZUMAB dosage: 703 MG, Q2W. During the same period patient was treated with IRINOTECAN, LISINOPRIL, LIPITOR, NORVASC, CLARINEX, AGGRENOX, KEPPRA, ASPIRIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603057-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 16, 2008. Male patient, weighting 180.3 lb, was diagnosed with pancreatic carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cholecystitis. BEVACIZUMAB dosage: unknown. During the same period patient was treated with GEMZAR, PROTONIX, GLUCOPHAGE, ZOFRAN, VICODIN, ZOCOR, ASPIRIN, LANTUS. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603061-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, pain, small intestinal obstruction. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TOPOTECAN, DILAUDID, ACETAMINOPHEN, BISACODYL, DIPHENHYDRAMINE, ERTAPENEM, FAT EMULSION, FENTANYL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603070-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 18, 2008. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: sepsis. BEVACIZUMAB dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient died on 12/05/2007.
Bevacizumab Side Effects Report #5603074-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, weighting 162.5 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: facial palsy. BEVACIZUMAB dosage: 703 MG, Q2W. During the same period patient was treated with IRINOTECAN, LISINOPRIL, LIPITOR, NORVASC, CLARINEX. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603086-1
Physician from AUSTRALIA reported BEVACIZUMAB problem on Jan 16, 2008. Female patient, weighting 101.4 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, renal failure acute. BEVACIZUMAB dosage: 7.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, MITOMYCIN, GASTRO, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5603087-3
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Jan 10, 2008. Male patient was diagnosed with colon cancer recurrent and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: back pain, muscle contractions involuntary. BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, NOVORAPID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5604818-9
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Jan 14, 2008. Female patient, weighting 137.6 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: gastritis. BEVACIZUMAB dosage: 1020 MG, Q3W. During the same period patient was treated with TAXOTERE, PACLITAXEL, HYDROMORPHONE, ARTHROTEC, CELEXA, BONEFOS, RAMIPRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5606094-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 15, 2008. Female patient was diagnosed with colon cancer, reflux oesophagitis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, platelet count decreased. BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, ISOVORIN, RABEPRAZOLE. Patient recovered.
Bevacizumab Side Effects Report #5606099-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 22, 2008. Male patient, weighting 160.0 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness. BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with ALIMTA, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5606115-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 22, 2008. Female patient, weighting 186.3 lb, was diagnosed with glioblastoma multiforme, fatigue, headache, insomnia, dyspepsia, hypothyroidism, depression, deep vein thrombosis, prophylaxis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood chloride increased. BEVACIZUMAB dosage: 745 MG, Q2W. During the same period patient was treated with PROVIGIL, CODEINE, AMBIEN, PROTONIX, LEVOTHYROXINE, NORTRIPTYLINE, LOVENOX, KEPPRA. Patient was